Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

ClinicalTrials.gov ID: NCT04605991

Public ClinicalTrials.gov record NCT04605991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring

Study identification

NCT ID
NCT04605991
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

  • Insulin Glargine Drug
  • LY900014 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 3, 2020
Primary completion
Feb 3, 2022
Completion
Feb 3, 2022
Last update posted
Mar 2, 2023

2020 – 2022

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
John Muir Physician Network Clinical Research Center Concord California 94520
AMCR Institute Escondido California 92025
Valley Endocrine, Fresno Fresno California 93720
University Clinical Investigators, Inc. Tustin California 92780
Coastal Metabolic Research Centre Ventura California 93003
CMR of Greater New Haven Hamden Connecticut 06517
Encore Medical Research Hollywood Florida 33021
Sun Coast Clinical Research, Inc New Port Richey Florida 34652
Metabolic Research Institute, Inc. West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30318
East Coast Institute for Research at The Jones Center Macon Georgia 31210
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative Springfield Illinois 62711
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Maryland Cardiovascular Specialists Baltimore Maryland 21229
Endocrine and Metabolic Consultants Rockville Maryland 20852
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Tenaya Las Vegas Nevada 89148
Research NYC, Inc New York New York 10016
Suny Health Science Center at Syracuse Syracuse New York 13210
Cataret Medical Group Morehead City North Carolina 28557
Intend Research, LLC Norman Oklahoma 73069
Texas Diabetes & Endocrinology, P.A. Austin Texas 78749
Dallas Diabetes Research Center Dallas Texas 75230
Biopharma Informatic, LLC Houston Texas 77043
Endocrine Ips, Pllc Houston Texas 77079
Consano Clinical Research, LLC Shavano Park Texas 78231
Burke Internal Medicine and Research Burke Virginia 22015
Manassas Clinical Research Center Manassas Virginia 20110
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04605991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2023 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04605991 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →